Ranbaxy Innovation and Growth Focus

APAC (excluding India) & Africa APAC and Africa are growth markets for the Company • Strong, growing presence in APAC ex India. • Manufacturing facility in Malaysia. • First company to launch generic Lipitor in Australia. Capitalize on DS's strengths in China, Japan & South Korea to claim high market share. • DS will be the front for Generic drugs from Ranbaxy in Japan. • Amongst the largest players in Africa with presence in over 40 countries. • Large presence in South Africa, Nigeria etc. Manufacturing in 3 countries in the region. RANBAXY Trusted medicines.Healthier lives 19

View entire presentation